BDRL — Blonder Tongue Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- $0.46m
- $5.06m
- $11.17m
Annual cashflow statement for Blonder Tongue Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.47 | 0.084 | -2.92 | -2.12 | -1.25 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.828 | -0.725 | 1.26 | 0.517 | 0.222 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.33 | -1.67 | -0.615 | 2.76 | 1.22 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Cash from Operating Activities | -3.21 | -1.17 | -1.38 | 1.99 | 1.04 |
| Capital Expenditures | -0.191 | -0.086 | -0.055 | -0.647 | -0.011 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | 0.004 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.191 | -0.086 | -0.055 | -0.647 | -0.007 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.9 | 1.46 | 1.24 | -1.41 | -1.01 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.503 | 0.205 | -0.195 | -0.071 | 0.025 |